HLA Class I Allele Expression and Clinical Outcome in De Novo Metastatic Prostate Cancer.

Cancers (Basel) · 2020 · PMC7352811 · PMID 32570992

Europe PMC DOI

hedged sentence

0.0794

closest p · 1.6× alpha

0.0794

boldest claim

The sentences

a strong trendp = 0.0794so close (0.05 < p ≤ 0.1)

HLA-A*24:02 + HLA-A*202:01 − patients showed a strong trend for improved OS than HLA-A*24:02−HLA-A*02:01 + patients (zero vs. seven deaths at four years postdiagnosis, respectively; Gehan-Breslow, p = 0.0794) ( Figure 2 c). 2.3.

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.